Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 1200 of 1322 entries
View as:

Stimulus Intensity in Left Ventricular Leads

Phase: N/A Priority: Normal
NCT ID: NCT01060449 Org: User:
Start: 08/31/08 End: 02/29/12 Due: 02/28/13

Improving Health-Promoting Behaviors in Adolescent Cancer Survivors Using AWAKE: A Feasibility Trial

Phase: N/A Priority: Normal
NCT ID: NCT03564587 Org: User:
Start: 06/20/18 End: 09/15/20 Due: 09/15/21

Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03819088 Org: User:
Start: 04/17/19 End: 10/05/21 Due: 10/05/22

Exparel vs. Standard Bupivicaine for Abdominoplasty

Phase: N/A Priority: Normal
NCT ID: NCT01853176 Org: User:
Start: 05/31/13 End: 07/31/14 Due: 07/31/15

Immune Response to Hepatitis C Virus

Phase: N/A Priority: Normal
NCT ID: NCT00165919 Org: User:
Start: 09/30/05 End: 09/30/05 Due: 09/30/06

Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children

Phase: N/A Priority: Normal
NCT ID: NCT02610881 Org: User:
Start: 12/31/15 End: 04/30/16 Due: 04/30/17

Resynchronization Therapy in Young Patients With and Without CHD

Phase: N/A Priority: Normal
NCT ID: NCT00208806 Org: User:
Start: 06/30/04 End: 12/31/06 Due: 12/31/07

Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)

Phase: N/A Priority: Normal
NCT ID: NCT00743756 Org: User:
Start: 04/30/06 End: 12/31/09 Due: 12/31/10

Paravertebral Nerve Blocks in Neonates

Phase: N/A Priority: Normal
NCT ID: NCT03408340 Org: User:
Start: 07/18/18 End: 07/28/20 Due: 07/28/21

DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)

Phase: N/A Priority: Normal
NCT ID: NCT05795842 Org: User:
Start: 03/21/23 End: 12/31/28 Due: 12/31/29

Asthma Navigator Intervention to Improve Health Equity in Children

Phase: N/A Priority: Normal
NCT ID: NCT06513832 Org: User:
Start: 01/17/25 End: 08/31/26 Due: 08/31/27

New Strategies to Assess Anal Cancer Risk In Women

Phase: N/A Priority: Normal
NCT ID: NCT02873741 Org: User:
Start: 07/31/16 End: 02/27/17 Due: 02/27/18

Sensorimotor Gating in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00561561 Org: User:
Start: 06/30/01 End: 08/26/11 Due: 08/26/12

Inflammation and Depression in People With HIV

Phase: N/A Priority: Normal
NCT ID: NCT05849038 Org: User:
Start: 12/11/23 End: 11/30/27 Due: 11/30/28

STRIDE Biorepository

Phase: N/A Priority: Normal
NCT ID: NCT02843347 Org: User:
Start: 03/13/17 End: 07/31/23 Due: 07/31/24

Heparin Management During Cardiopulmonary Bypass in Children

Phase: N/A Priority: Normal
NCT ID: NCT00146653 Org: User:
Start: 12/31/05 End: 01/31/10 Due: 01/31/11

Exercise is Medicine at Emory Seavey Internal Medicine Clinic

Phase: N/A Priority: Normal
NCT ID: NCT03416634 Org: User:
Start: 08/20/18 End: 02/01/20 Due: 02/01/21

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01272141 Org: User:
Start: 12/31/10 End: 01/31/14 Due: 01/31/15

CAndesartan vs LIsinopril Effects on the BRain

Phase: N/A Priority: Normal
NCT ID: NCT01984164 Org: User:
Start: 08/20/14 End: 12/03/18 Due: 12/03/19

AflacLL1901 (CHOA-AML)

Phase: N/A Priority: Normal
NCT ID: NCT04326439 Org: User:
Start: 01/24/20 End: 03/15/22 Due: 03/15/23

Water Versus Saline as Irrigation Fluid for Ureteroscopy

Phase: N/A Priority: Normal
NCT ID: NCT03794102 Org: User:
Start: 01/17/17 End: 06/30/18 Due: 06/30/19

Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04262869 Org: User:
Start: 03/27/20 End: 10/18/21 Due: 10/18/22

Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation

Phase: N/A Priority: Normal
NCT ID: NCT00663143 Org: User:
Start: 07/31/09 End: 12/31/10 Due: 12/31/11

Influenza Human Challenge Model

Phase: N/A Priority: Normal
NCT ID: NCT05332899 Org: User:
Start: 05/24/22 End: 12/31/27 Due: 12/31/28

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06492759 Org: User:
Start: 04/30/25 End: 02/13/27 Due: 02/13/28